Experiences of Kratom Users: A Qualitative Analysis

REFERENCES

• Azizi, J., S. Ismail, M. N. Mordi, S. Ramanathan, M. I. M. Said, and S. M. Mansor. 2010. In vitro and in vivo effects of three different Mitragyna speciosa korth leaf extracts on phase II drug metabolizing enzymes glutathione transferases (GSTS). Molecules 15:432–41. doi:10.3390/molecules15010432.
   PubMed Web of Science ®Google Scholar
• Bachhuber, M. A., B. Saloner, C. O. Cunningham, and C. L. Barry. 2014. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Internal Medicine 174:1668–73. doi:10.1001/jamainternmed.2014.4005.
   PubMed Web of Science ®Google Scholar
• Backstrom, B. G., G. Classon, P. Lowenhielm, and G. Thelander. 2010. Krypton–ny, dodlig Internetdrog. Sedan oktober 2009 har nio unga personer dott i Sverige. [Krypton–new, deadly Internet drug. Since October 2009 nine young persons have died in Sweden]. Lakartidningen 107:3196–97.
   PubMedGoogle Scholar
• Barratt, M. J., M. Allen, and S. Lenton. 2014. “PMA sounds fun”: Negotiating drug discourses online. Substance Use & Misuse 49:987–98. doi:10.3109/10826084.2013.852584.
   PubMed Web of Science ®Google Scholar
• Botpiboon, O., S. Prutipanlai, B. Janchawee, and S. Thainchaiwattana. 2007. Effects of caffeine and codeine on antinociceptive activity of alkaloid extract from leaves of kratom (Mitragyna speciosa korth). Paper presented at the 35th Congress on Science and Technology of Thailand, The Tide Resort (Bangsaen Beach), Chonburi, Thailand, October 15-17, 2009.
   Google Scholar
• Boyer, E. W., K. M. Babu, J. E. Adkins, C. R. McCurdy, and J. H. Halpern. 2008. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction 103:1048–50. doi:10.1111/j.1360-0443.2008.02209.x.
   PubMed Web of Science ®Google Scholar
• Burkill, I. H. (Ed.). 1935. A dictionary of the economic products of the Malay Peninsula, Vol. II, London: Crown Agents for the Colonies.
   Google Scholar
• Chittrakam, S., P. Penjamras, and N. Keawpradub. 2012. Quantitative analysis of mitragynine, codeine, caffeine, chlorpheniramine and phenylephrine in a kratom (mitragyna speciosa korth) cocktail using high-performance liquid chromatography. Forensic Science International 217:81–86. doi:10.1016/j.forsciint.2011.10.027.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration, U.S. Department of Justice. 2013. Kratom (Mitragyna speciosa korth). Retrieved 10/18/15. http://www.deadiversion.usdoj.gov/drug_chem_info/kratom.pdf
   Google Scholar
• Erowid, E., and F. Erowid The value of experience. Erowid Extracts. June 2006 (10):14–19. https://erowid.org/experiences/exp_info3.shtml.
   Google Scholar
• Hassan, Z., M. Muzaimi, V. Navaratnam, N. H. Yusoff, F. W. Suhaimi, R. Vadivelu, B. K. Vicknasingam, et al. 2013. From kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews 37:138–51. doi:10.1016/j.neubiorev.2012.11.012.
   PubMed Web of Science ®Google Scholar
• Hsieh, H. F., and S. E. Shannon. 2005. Three approaches to qualitative content analysis. Qualitative Health Research 15:1277–88. doi:10.1177/1049732305276687.
   PubMed Web of Science ®Google Scholar
• Kapp, F. G., H. H. Maurer, V. Auwarter, M. Winkelmann, and M. Hermanns-Clausen. 2011. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). Journal of Medical Toxicology 7:227–31. doi:10.1007/s13181-011-0155-5.
   PubMedGoogle Scholar
• Kronstrand, R., M. Roman, G. Thelander, and A. Eriksson. 2011. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend krypton. Journal of Analytical Toxicology 35:242–47. doi:10.1093/anatox/35.4.242.
   PubMed Web of Science ®Google Scholar
• Lu, S., B. N. Tran, J. L. Nelsen, and K. M. Aldous. 2009. Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 877:2499–505. doi:10.1016/j.jchromb.2009.06.024.
   PubMed Web of Science ®Google Scholar
• Lucas, P. 2012. Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of Psychoactive Drugs 44:125–33. doi:10.1080/02791072.2012.684624.
   PubMed Web of Science ®Google Scholar
• Macko, E., J. A. Weisbach, and B. Douglas. 1972. Some observations on the pharmacology of mitragynine. Archives Internationales de Pharmacodynamie et de Therapie 198:145–61.
   PubMedGoogle Scholar
• Matsumoto, K., L. T. Yamamoto, K. Watanabe, S. Yano, J. Shan, P. K. T. Pang, D. Ponglux, H. Takayama, and S. Horie. 2005. Inhibitory effect of mitragynine, an analgesic from Thai herbal medicine, on neurogenic contraction of the vas deferens. Life Sciences 78:187–94.
   PubMed Web of Science ®Google Scholar
• Matsumoto, K., H. Takayama, M. Narita, A. Nakamura, M. Suzuki, T. Suzuki, T. Marayama, et al. 2008. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxy indolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: A novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice. Neuropharmacology 55:154–65. doi:10.1016/j.neuropharm.2008.05.003.
   PubMed Web of Science ®Google Scholar
• McIntyre, I. M., A. Trochta, S. Stolberg, and S. C. Campman. 2015. Mitragynine “kratom”-related fatality: A case report with postmortem concentrations. Journal of Analytical Toxicology 39:152–55. doi:10.1093/jat/bku137.
   PubMed Web of Science ®Google Scholar
• McWhirter, L., and S. Morris. 2010. A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. European Addiction Research 16:229–31. doi:10.1159/000320288.
   PubMed Web of Science ®Google Scholar
• Mikuriya T. 2004. Cannabis as a substitute for alcohol: A harm reduction approach. J Cannabis Therapeutics 4:79–93.
   Google Scholar
• Müller, C. P., and G. Schumann. 2011. Drugs as instruments: A new framework for non-addictive psychoactive drug use. Behavioral and Brain Sciences 34:293–310. doi:10.1017/S0140525X11000057.
   PubMed Web of Science ®Google Scholar
• Neerman, M. F., R. E. Frost, and J. Deking. 2013. A drug fatality involving kratom. Journal of Forensic Sciences 58 (Suppl 1):SS278–9. doi:10.1111/1556-4029.12009.
   Web of Science ®Google Scholar
• Nelsen, J. L., J. Lapoint, M. J. Hodgman, and K. M. Aldous. 2010. Seizure and coma following kratom (Mitragynina speciosa korth) exposure. Journal of Medical Toxicology 6:424–26. doi:10.1007/s13181-010-0079-5.
   PubMedGoogle Scholar
• Parthasarathy, S., J. Bin Azizi, S. Ramanathan, S. Ismail, S. Sasidharan, M. I. Said, and S. M. Mansor. 2009. Evaluation of antioxidant and antibacterial activities of aqueous, methanolic and alkaloid extracts from Mitragyna speciosa (Rubiaceae family) leaves. Molecules 14:3964–74. doi:10.3390/molecules14103964.
   PubMed Web of Science ®Google Scholar
• Prozialeck, W. C., J. K. Jivan, and S. V. Andurkar. 2012. Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. The Journal of the American Osteopathic Association 112 (12):792–99.
   PubMedGoogle Scholar
• Ramesh, D., G. R. Ross, J. E. Schlosburg, R. A. Owens, A. Abdullah, S. G. Kinsey, J. Z. Long, D. K. Nomura, L. J. Sim-Selley, B. F. Cravatt, H. I. Akbarali, and A. H. Lichtman. 2011. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice. J Pharmacololgy & Experimental Therapeutics 339:173–85. doi:10.1124/jpet.111.181370
   PubMed Web of Science ®Google Scholar
• Reanmongkol, W., A. Itharat, and P. Bouking. 2007. Evaluation of the anti-inflammatory, antinociceptive and antipyretic activities of the extracts from Smilax corbularia Kunth rhizomes in mice and rats (in vivo). The Songklanakarin Journal of Science and Technology 29:59–67.
   Google Scholar
• Roche, K. M., K. Hart, B. Sangalli, J. Lefberg, and M. Bayer. 2008. Kratom: A case of a legal high. Clinical Toxicology 46 (7):598.
   Web of Science ®Google Scholar
• Sabetghadam, A., S. Ramanathan, and S. M. Mansor. 2010. The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa korth leaves in rats. Pharmacognosy Research 2:181–85. doi:10.4103/0974-8490.65514.
   PubMedGoogle Scholar
• Shaik Mossadeq, W. M., K. Syamimi, M. P. Azyyati, Z. A. Zakaria, A. K. Arifah, M. A. Rajion, M. L. Jabit, M. Taufik Hidayat, and M. R. Sulaiman. 2009. Anti-inflammatory effect of Mitragyna speciosa crude methanol extract on the guinea pig ileum. Planta Medica 75:PH19. doi:10.1055/s-0029-1234736.
   Web of Science ®Google Scholar
• Sheleg, S. V., and G. B. Collins. 2011. A coincidence of addiction to “kratom” and severe primary hypothyroidism. Journal of Addiction Medicine 5:300–01. doi:10.1097/ADM.0b013e318221fbfa.
   PubMed Web of Science ®Google Scholar
• Singh, D., C. P. Müller, and B. K. Vicknasingam. 2014. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence 139:132–37.doi: 10.1016/j.drugalcdep.2014.03.017.
   PubMed Web of Science ®Google Scholar
• Singh, D., C. P. Muller, B. K. Vicknasingam, and S. M. Mansor. 2015. Social functioning of kratom users in Malaysia. Journal of Psychoactive Drugs 47:125–31. doi:10.1080/02791072.2015.1012610.
   PubMed Web of Science ®Google Scholar
• Soussan, C., and A. Kjellgren. 2014. Harm reduction and knowledge exchange: A qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal 11:25–29. doi:10.1186/1477-7517-11-25.
   PubMed Web of Science ®Google Scholar
• Suwanlert, S. 1975. A study of kratom eaters in Thailand. Bulletin on Narcotics 27:21–27.
   PubMedGoogle Scholar
• Tanguay, P. 2011. Kratom in Thailand: Decriminalisation and community control? Legislative Reform of Drug Policies 13:1–16.
   Google Scholar
• Vicknasingam, B., S. Narayanan, G. T. Beng, and S. M. Mansor. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy 21:283–88. doi:10.1016/j.drugpo.2009.12.003.
   PubMed Web of Science ®Google Scholar
• Ward, J., C. Rosenbaum, C. Hernon, C. R. McCurdy, and E. W. Boyer. 2011. Herbal medicines for the management of opioid addiction: Safe and effective alternatives to conventional pharmacotherapy? CNS Drugs 25 (December):999–1007. doi:10.2165/11596830-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Watanabe, K., S. Yano, S. Horie, and L. T. Yamamoto. 1997. Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor. Life Sciences 60:933–42. doi:10.1016/S0024-3205(97)00023-4.
   PubMed Web of Science ®Google Scholar
• Yamamoto, L. T., S. Horie, H. Takayama, N. Aimi, S. Sakai, S. Yano, J. Shan, P. K. Pang, D. Ponglux, and K. Watanabe. 1999. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. General Pharmacology 33::73–81. doi:10.1016/S0306-3623(98)00265-1.
   PubMedGoogle Scholar
• Yusoff, N. H., F. W. Suhaimi, R. K. Vadivelu, Z. Hassan, A. Rümler, A. Rotter, D. Amato, H. C. Dringenberg, S. M. Mansor, V. Navaratnam, and C. P. Müller. 2014. Abuse potential and adverse cognitive effects of mitragynine (kratom). Addiction Biology. Article first published online: 28 SEP 2014 DOI:10.1111/adb.12185
   Google Scholar